Abstract Background/Aims: Transplantation of bone-marrow derived stem/progenitor cells has an established therapeutic effect on cardiac muscle repair after injury. However, the exact mechanism that underlies this phenomenon is not completely understood. Methods: Here we transplanted mesenchymal stem cells (MSCs), a major population from the bone-marrow derived stem/progenitor cells, and studied its effects on cardiac muscle repair after injury. Results: MSCs transplantation significantly improved cardiac muscle repair after injury. The grafted MSCs did not significantly differentiate into cardiac muscle cells themselves, but appeared to induce neovascularization in the injured heart. In a loss-of-function experiment, we further show that production and secretion of placental growth factor, but not vascular endothelial growth factor A in MSCs, were essential for the MSCs-induced neovasularization after cardiac muscle injury to facilitate cardiac muscle repair. Conclusion: Our study thus sheds light on an undescribed role of placental growth factor in cardiac muscle regeneration.
Introduction
Bone marrow-derived stem/progenitor cells can mediate neovascularization in the ischemic myocardium and improve heart function [1, 2] . However, the underlying mechanism remains unclear [3] [4] [5] . Moreover, significant variability of the responses to using bone marrow-derived stem/progenitor cells may largely result from the feature of bone marrow-derived stem/progenitor cells as a mixture of different cell types [3] [4] [5] [6] . Mesenchymal stem cells (MSCs) are the most important population of bone marrow-derived stem/progenitor cells. Cells similar to bone marrow-derived MSCs have now been identified in all postnatal tissues, and play essential roles in the renewal and repair of various tissues [7] [8] [9] [10] [11] [12] . Determination of the biological properties of MSCs has enabled successful revision of the role of MSCs in various organs and tissues [7] [8] [9] [10] [11] [12] .
In the current study, we addressed the question of whether MSCs are the functional part of bone marrow-derived stem/progenitor cells that is capable of promoting cardiac muscle repair after injury, and of what the underlying molecular mechanism is. We found that MSCs transplantation significantly improved cardiac muscle repair after injury. The grafted MSCs did not significantly differentiate into cardiac muscle cells themselves, but appeared to contribute to neovascularization in the injured heart, by production and secretion of placental growth factor (PLGF), but not vascular endothelial growth factor A (VEGF-A).
Materials and Methods

Mouse handling
All mouse experiments were approved by the Institutional Animal Care and Use Committee at Ruijin Hospital, Shanghai Jiaotong University School of Medicine (Animal Welfare Assurance). Surgeries were performed under ketamine/xylazine anesthesia, in accordance with the Principles of Laboratory Care, supervised by a qualified veterinarian. All efforts were made to minimize pain and suffering. Male C57BL/6 mice of 12 weeks of age were used in the current study. Six mice were analyzed in each experimental condition.
Acute myocardial infarction (AMI) model
A standardized mouse AMI model was applied as has been described before [13] . Briefly, after the mice were anesthetized with ketamine/xylazine, they were orally intubated with 22 GIV catheter and artificially ventilated with a respirator (Harvard Apparatus, Boston, MA, USA). A small oblique thoracotomy was performed lateral to the left intercostal line in the third costal space to expose the heart. After the pericardium was opened, the proximal left anterior descending artery (LAD) branch of the left coronary artery was ligated using 8-0 gauge polypropylene sutures through a dissecting microscope.
MSCs transplantation For MSCs transplantation, 10
6 MSCs were intravenously injected via tail vein to the mice immediately after surgical induction of AMI.
Heart function evaluation
Mice underwent echocardiography just before MI (0 week) and at 1, 2, and 4 weeks after AMI as has been described before [13] . Transthoracic echocardiography was performed with a 6-to 15-MHz transducer (SONOS 5500, Hewlett Packard, Los Angeles, CA, USA). Two-dimensional images were obtained in the parasternal long and short axis and apical 4-chamber views. M-mode images of the left ventricular (LV) short axis were taken just below the level of mid-papillary muscles. LV end-diastolic and end-systolic dimensions were measured and functional shortening was determined according to modified recommendations of the American Society of Echocardiography. A mean value of 3 measurements was determined for each time point.
MSCs isolation, culturing and differentiation
The MSCs were isolated and grown in culture as has been described previously [11, 14, 15] . Briefly, plugs of marrow from five 12-week-old male C57/6BL mice (about 30g body weight) were dispersed MSC were induced with 5ml chondrogenetic induction medium containing 10μg transforming growth factor β1 (R&D System, Los Angeles, CA,USA), 50μg insulin growth factor 1 (R&D System), and 2mg/mL dexamethasone (DMSO, Sigma-Aldrich, St. Louis, MO, USA) followed by centrifugation at 500g for 5 min. The cell pellets were maintained in the chondrogenetic induction medium for 14 days and subjected to Alcian blue staining. For osteogenic induction, cells were digested and seeded onto a 24-well plate at a density of 10 4 cells/well, and then maintained in osteogenic induction medium containing 10nM Vitamin D3 (Sigma-Aldrich) and 10mM β-phosphoglycerol and 0.1µM DMSO for 14 days and were subjected to Von kossa staining. For adipogenic induction, cells were digested and seeded onto a 24-well plate at a density of 10 4 cells/well, and then maintained in the adipogenic induction medium containing 0.5mM 3-isobutyl-1-methylxanthine (IBMX), 200µM indomethacin, 10µM insulin and 1µM DMSO for 14 days and subjected to Oil red O staining.
CFSE labeling of MSCs
CFDA-SE (CFSE, Invitrogen, St. Louis, MO, USA) was prepared according to the manufacturer's instruction. Cultured cells were incubated with 10μM CFSE for 10 minutes, resulting in efficient sustained labeling of the cells, as has been described before [16, 17] . The cells were then extensively washed with PBS to remove extracellular CFSE in the media before transplantation. CFSE-labeled MSCs were then purified by flow cytometry based on green fluorescence.
Knockdown of VEGF-A or PLGF in MSCs
Recombinant lenti-viruses expressing short hair interfering RNA (shRNAs) for VEGF-A or PLGF together with a GFP reporter under the control of CMV promoter (Invivogen Therapeutics, Toulouse, France) efficiently infected MSCs at MOI 100 and resulted in nearly 100% infection efficiency, based on GFP expression. The sequence for shVEGF-A is 5'-TGTGAATGCAGACCAAAGA-3', as has been described before [18] . ShPLGF was purchased from Qiagen (Hilden, Germany).
Flow cytometry
The mouse hearts were digested into single cells as has been described before [19] . The digests were incubated either with M-cadherin antibody (M-Cad, Millipore, Billerica, MA, USA), or with CD31 antibody (Becton-Dickinson Biosciences), or F4/80 (ebioscience, San Diego, CA, USA) followed by labeling with PE-conjugated anti-mouse second antibody (Becton-Dickinson Biosciences). Afterwards, flow cytometry analysis was performed in a FACSAria flow cytometer. MSCs were recognized by direct fluorescence of CFSE.
Immunohistochemistry
Mouse hearts were dissected out and fixed with 4% paraformaldehyde for 6 hours, and then cryoprotected in 20% sucrose overnight. Samples were then sectioned at 6μM. For immunostaining, primary antibodies are rat anti-CD31 (Becton-Dickinson Biosciences) and rabbit anti-M-cadherin (M-Cad, Millipore). Secondary antibodies were Cy3-and Cy2-conjugated antibodies for corresponding species (Jackson Labs, Bar Harbor, ME, USA). CFSE was visualized by direct green fluorescence. DAPI was used to stain nucleus. Vessel density was determined with NIH ImageJ software by measuring the percentage of CD31-positive area to the total heart area. For quantification of heart fibrosis, heart sections were stained with Masson trichrome as has been described before [20] . Evaluation of heart fibrosis in each sample was performed based on 20 randomly selected fields per section, which were examined under ×400 magnification for assessment of the degree of heart fibrosis by visualizing blue-stained areas, exclusive of staining that colocalized with perivascular or intramural vascular structures, the endocardium, or LV trabeculae. ImageJ software was used to determine blue-stained areas and non-stained myocyte areas from each section using a color-based threshold. The percentage of total fibrosis area was calculated as the summed blue-stained areas divided by total ventricular area, as has been described previously [21] .
Quantitative real-time PCR (RT-qPCR)
RNA was extracted from cultured cells with RNeasy (Qiagen) for cDNA synthesis. RT-qPCR was performed in duplicates with QuantiTect SYBR Green PCR Kit (Qiagen). All primers were purchased from Qiagen. Values of genes were normalized against α-tubulin and then compared to the control (=1).
ELISA
The protein levels of VEGF-A and PLGF were determined by a VEGF-A and a PLGF ELISA kit (Raybio, Norcross, GA, USA), respectively. ELISAs were performed according to the instructions of the manufacturer. Briefly, the cell lysates were added to a well coated with VEGF-A/PLGF polyclonal antibody, and then immunosorbented by biotinylated monoclonal anti-human VEGF-A/PLGF antibody at room temperature for 2 hours. The color development catalyzed by horseradish peroxidase was terminated with 2.5mol/l sulfuric acid and the absorption was measured at 450 nm. The protein concentration was determined by comparing the relative absorbance of the samples with the standards. Each sample was assayed in duplicates and the mean value was taken for statistical analysis.
Western blot
Protein was extracted from the cultured cells by RIPA buffer (Sigma-Aldrich) for Western Blot. The supernatants were collected after centrifugation at 12000×g at 4°C for 20min. Protein concentration was determined using BCA protein assay, and whole lysates were mixed with 4×SDS loading buffer (125 mmol/L Tris-HCl, 4% SDS, 20% glycerol, 100 mmol/L DTT, and 0.2% bromophenol blue) at a ratio of 1:3. Samples were heated at 100 °C for 5 min and were separated on SDS-polyacrylamide gels. The separated proteins were then transferred to a PVDF membrane. The membrane blots were first probed with a primary antibody. After incubation with horseradish peroxidase-conjugated second antibody, autoradiograms were prepared using the enhanced chemiluminescent system to visualize the protein antigen. The signals were recorded using X-ray film. Primary antibodies for Western Blot are anti-phosphorylated-Flt-1 (pFlt-1, tyr1213, Millipore), anti-phosphorylated-ERK1/2 (pERK1/2, tyr202/204, Cell Signaling, San Jose, CA, USA), antiphosphorylated-Akt (pAkt, ser473, Cell Signaling) and anti-α-tubulin (Cell Signaling). Secondary antibody is HRP-conjugated anti-rabbit (Jackson Labs). Images shown in the figure were representative from 5 repeats. Recombinant PLGF was purchased from Sigma-Aldrich, and used in a dose of 10nmol/l.
Statistics
All values are depicted as mean ± standard deviation from 6 individuals and are considered significant if p < 0.05. All data were statistically analyzed using one-way ANOVA with a Bonferoni correction.
Results
Isolation, culturing, differentiation and labeling of primary mouse MSCs
Primary mouse MSCs were isolated from male C57BL/6 mice and expanded in culture. After 10 passages' selection of attached cells, the cells were sorted for Stro-1, the best MSC marker [22, 23] , by flow cytometry to get rid of contaminating cells (Fig. 1A) . Our data show that more than 95% cultured cells are Stro-1-positive. Differentiation assays were performed, including Von kossa staining to evaluate osteogenic induction, Oil red O staining to evaluate adipogenic induction and Alcian blue staining to evaluate chondrogenetic, which confirmed MSCs phenotype (Fig. 1B-D) . Immediately before transplantation, the MSCs were labeled with CFSE, to allow in vivo lineage tracing (Fig. 1E) . Successfully labeled MSCs were purified by flow cytometry (Fig. 1F) .
Grafted MSCs improved heart function after cardiac muscle injury in isogenic mice
In order to evaluate the effect of transplantation of MSCs on injured heart, we transplanted CFSE-labeled MSCs immediately after induction of AMI, as has been described before [13] . LV end-diastolic and end-systolic dimensions were measured and functional shortening was determined before AMI (week 0) and on 1, 2, 3 and 4 weeks post-AMI. The echocardiography 2, 3, 4 weeks post-AMI showed significantly improved LV diastolic dimensions (LVDd) ( Fig. 2A ) and percentage of LV fractional shortening (LVFS) (Fig. 2B ) in mice transplanted with MSCs compared to PBS control. Masson's Trichrome-stained sections showed markedly reduced levels of LV fibrosis, by representative images (Fig. 2C) , and by quantification (Fig.  2D) . Moreover, cardiac vessel density was quantified by CD31 positivity, showing significant increase in the LV from the mice that received MSCs after AMI (Fig. 2E-F) . These data suggest that grafted MSCs may improve heart function after cardiac muscle injury in isogenic mice.
Direct contribution of grafted MSCs to cardiac muscle cells was very limited
We next examined whether grafted MSCs may contribute to the regeneration of the injured cardiac muscle by direct differentiation. Although we detected many CFSE-positive MSCs in the injured heart of MSCs-treated mice, it is technically difficult to evaluate and quantify the CFSE-positive cardiac muscle cells (Fig. 3A) . Therefore, we digested the mouse 
Conclusion
Production and secretion of PLGF, but not of VEGF-A in MSCs, were essential for the MSCs-induced neovasularization after cardiac muscle injury to facilitate cardiac muscle repair.
Discussion
Transplantation of bone-marrow derived stem/progenitor cells has an established therapeutic effect on cardiac muscle repair after injury. However, previous studies have controversial results on the underlying mechanism [3] [4] [5] [6] , which prompted us to address this question by using MSCs, a unique population in bone-marrow derived stem/progenitor cells.
We chose C57BL/6 mice for our study, since it is a strict inbred strain, which allows isogenic transplantation. We first isolated and cultured primary mouse MSCs from male C57BL/6 mice, and assured the phenotypes of MSCs by three differentiation assays. Immediately before transplantation, the MSCs were labeled with CFSE, for the purpose of in vivo lineage tracing. According to previous publications, CFSE (carboxyfluorescein diacetate, succinimidyl ester) is a cell-tagged dye that passively enters the cells, and then is retained within the cells without leaking out. It will dilute during cell proliferation, but the high level of fluorescence allows the daughter cells to be detected within 5-7 cell cycles [16, 27] . Thus, this method is proper for our study.
In order to evaluate the effect of transplantation of MSCs on injured heart, we transplanted CFSE-labeled MSCs immediately after induction of AMI. Significant improvement in LVDd and LVFS, reduced fibrosis, and increased vascularization in mice transplanted with MSCs demonstrate a role for MSCs in cardiac muscle repair. CFSE-labeling of the grafted MSCs allows lineage tracing of these cells. By objective analysis of heart digests by flow cytometry, we found very limited contribution, suggesting that a direct contribution of MSCs to regenerated cardiac muscle cells is very limited, consistent with the results from majority of previous studies [28] [29] [30] .
Since neovascularization is critical for tissue repair, we thus examined the angiogenic factors in MSCs for promoting neovascularization. We examined levels of VEGF family members in MSCs, and found that MSCs expressed high levels of VEGF-A and PLGF, but low or null levels of other members. In order to figure out the roles of VEGF-A and PLGF in MSCs in cardiac regeneration, we knocked down VEGF-A or PLGF in MSCs by lenti-viruses expressing shVEGF-A or shPLGF, respectively. Of note, it is important to show that knockdown of VEGF-A in MSCs did not affect PLGF levels, and vice versa, which allows us to analyze the effect of VEGF-A and PLGF in MSCs separately. We then transplanted MSCs-shVEGF-A, MSCs-shPLGF, and control cells into AMI-mice, respectively. Our data show that the beneficial effects of 
